The table below shows WEST PHARMACEUTICAL SERVICES INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$2.89B
$2.83B
$2.15B
Cost of revenue
$1.97B
$1.89B
$1.82B
$1.75B
$1.66B
$1.38B
Gross profit
$1.10B
$998.50M
$1.13B
$1.14B
$1.18B
$767.80M
R&D
$74.30M
$69.10M
$68.40M
$58.50M
$52.80M
$46.90M
SG&A
WST annual revenue (10-K history)
WEST PHARMACEUTICAL SERVICES INC reported annual revenue of $3.07B for fiscal year 2025. That is up 6.3% from $2.89B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.51B (FY 2016) to $3.07B. Figures come from the company's audited annual reports as filed with the SEC.
